Medifast MED Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 71.3%-2.5pp | 73.8%+1.4pp | 72.4%+1.0pp | 71.3%-2.5pp | |
| Operating margin | -3.7%-4.2pp | 0.5%-11.3pp | 11.8%+0.2pp | 11.6%-2.6pp | |
| Net margin | -4.8%-5.2pp | 0.3%-8.9pp | 9.3%+0.3pp | 9%-1.8pp | |
| EBITDA margin | 0%-2.6pp | 2.6%-10.4pp | 13%+0.8pp | 12.2%-2.4pp | |
| Returns | |||||
| Return on equity | -9.1%-10.1pp | 1%-54.8pp | 55.8%-24.5pp | 80.3%-10.9pp | |
| Return on assets | -7%-7.7pp | 0.7%-31.1pp | 31.8%-8.4pp | 40.2%-8.5pp | |
| Return on invested capital | -11.1%-12.3pp | 1.2%-86.5pp | 87.7%-40.9pp | 128.6%-114pp | |
| Efficiency | |||||
| Asset turnover | 1.4×-0.6× | 2×-1.4× | 3.4×-1.1× | 4.5×-0.1× | |
| Inventory turnover | 3.5×+0.3× | 3.3×-0.2× | 3.4×+0.3× | 3.1×-0.3× | |
| Liquidity | |||||
| Current ratio | 4.7×+1.4× | 3.3×+0.9× | 2.4×+0.8× | 1.6×-0.2× | |
| Quick ratio | 4.2×+1.5× | 2.7×+0.8× | 1.8×+1.1× | 0.7×0.0× | |
| Cash ratio | 2.1×+0.7× | 1.4×+0.4× | 1×+0.4× | 0.6×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.2×0.0× | |
| Debt-to-assets | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -2,620.3×-2,616× | -4.8×-4.3× | -0.5×-0.2× | -0.3×0.0× | |
| Interest coverage | -2.6×-3.2× | 0.6×-50.2× | 50.8×— | —— | |
| Per Share | |||||
| Book value per share | $18.11-5.5% | $19.17+3.9% | $18.45+34.2% | $13.75-19.8% | |
| Valuation | |||||
| Market capitalization | $121.87M-17.4% | $192.72M-73.7% | $732.23M-41.9% | $1.26B-48.2% | |
| Enterprise value | $66.44M+12.8% | $117.92M-82.1% | $659.8M-45.0% | $1.2B-49.2% | |
| Price / sales | 0.4×0.0× | 0.3×-0.4× | 0.7×-0.1× | 0.8×-0.8× | |
| Price / book | 0.6×-0.1× | 0.9×-2.7× | 3.6×-4.5× | 8.1×-3.9× | |
| EV / EBITDA | 1,292.6×+1,285× | 7.6×+2.8× | 4.7×-1.4× | 6.1×-4.5× | |
| EV / sales | 0.2×+0.1× | 0.2×-0.4× | 0.6×-0.1× | 0.7×-0.8× | |
| Earnings yield | -16.4%-18.9pp | 1.1%-12.5pp | 13.6%+2.2pp | 11.4%+4.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Medifast's profit margins?
- Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.
- Where do Medifast's ratios come from?
- Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
